Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XLV vs MEDX overlap: 47% of top holdings shared

Bottom line

How much do XLV and MEDX overlap?

47% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 49.3% of XLV's assets and 50.1% of MEDX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

XLVMEDX
Weight overlap (top 25)47%
Shared holdings8
Weight in shared holdings49.3%50.1%
Total positions6533
Expense ratio0.08%0.85%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings XLV and MEDX have in common

Holding% of XLV% of MEDXOverlap
Eli Lilly & Co16.51%18.46%16.51%
Johnson & Johnson10.64%5.59%5.59%
AbbVie Inc7.74%8.85%7.74%
Merck & Co Inc5.52%3.96%3.96%
Amgen Inc3.40%3.91%3.40%
Pfizer Inc2.39%2.86%2.39%
Bristol-Myers Squibb Co2.05%4.42%2.05%
Regeneron Pharmaceuticals Inc1.08%2.06%1.08%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XLV

  1. UnitedHealth Group Inc — 6.57%
  2. Thermo Fisher Scientific Inc — 3.24%
  3. Abbott Laboratories — 2.75%
  4. Gilead Sciences Inc — 2.73%
  5. Intuitive Surgical Inc — 2.45%
  6. CVS Health Corp — 2.30%
  7. Vertex Pharmaceuticals Inc — 2.19%
  8. Danaher Corp — 2.09%
  9. Stryker Corp — 1.89%
  10. Medtronic PLC — 1.75%
  11. McKesson Corp — 1.58%
  12. Elevance Health Inc — 1.46%
  13. Cigna Group/The — 1.27%
  14. Boston Scientific Corp — 1.10%
  15. HCA Healthcare Inc — 1.05%

Only in MEDX

  1. US Bank Mmda - Usbgfs 7 — 9.19%
  2. Novartis AG — 6.89%
  3. Alkermes PLC — 5.53%
  4. AstraZeneca PLC — 4.98%
  5. Ionis Pharmaceuticals Inc — 4.53%
  6. Alnylam Pharmaceuticals Inc — 3.42%
  7. Biogen Inc — 3.09%
  8. Gsk Plc — 2.71%
  9. CRISPR Therapeutics AG — 2.64%
  10. Beam Therapeutics Inc — 1.51%
  11. Galectin Therapeutics Inc — 1.14%
  12. Intellia Therapeutics Inc — 1.12%
  13. Sandoz Group AG — 0.80%
  14. Replimune Group Inc — 0.73%
  15. Vanda Pharmaceuticals Inc — 0.73%

Asset mix

Asset typeXLVMEDX
Stocks99.7%92.6%
Cash & short-term funds0.3%9.2%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryXLVMEDX
US97.9%77.4%
CH—10.3%
GB—8.6%
IE2.1%5.5%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do XLV and MEDX overlap?
About 47% by weight. 8 securities appear in both funds' top 25 holdings; they make up 49.3% of XLV's assets and 50.1% of MEDX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do XLV and MEDX have in common?
The largest shared holdings are Eli Lilly & Co, AbbVie Inc, Johnson & Johnson, Merck & Co Inc, Amgen Inc.
Should I own both XLV and MEDX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, XLV or MEDX?
XLV is broader, with 65 positions versus 33 for MEDX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.